title: RU 486 induced suppression of placental neutrophil elastase inhibitor levels.
abstract: After administration of RU 486 to pregnant cynomolgus monkeys, placental morphology varied from normal to pathological. In all cases (n = 5) circulating and placental PAPP-A levels were markedly suppressed by 76.0 per cent and 55.5 per cent, respectively. When fetal demise occurred within 24 h prior to caesarian section, morphological changes consistent with an active inflammatory (polymorphonuclear leukocytosis) reaction was readily observed at the utero-placental interface, degrading the chorionic villi. Whereas heparin-Sepharose fractionated aqueous extracts of placentae inhibited human neutrophil (or granulocyte) elastase (HGE) activity, extracts of placenta being degraded by host phagocytic-proteolytic defense system were rich in HGE activity. This study establishes: (1) the cynomolgus monkey as a model for PAPP-A studies, (2) that haemochorially implanted placentae produce PAPP-A, a heparin-binding inhibitor of HGE, (3) that administration of progesterone receptor antagonist suppressed placental PAPP-A synthesis, and (4) disrupted protease-protease inhibitor equilibrium at the feto-maternal interface. Thus supporting a role for progesterone in placental PAPP-A production and maintenance of a placental barrier against maternal phagocytic-proteolytic defenses.
authors: Department of Obstetrics and Gynaecology, Royal North Shore Hospital, St. Leonards, Sydney, Australia.
authors: M J
authors: MJ
authors: Sinosich
authors: J
authors: J
authors: Lee
authors: J P
authors: JP
authors: Wolf
authors: R F
authors: RF
authors: Williams
authors: G D
authors: GD
authors: Hodgen
mesh_terms: D000284:Administration, Oral; D000818:Animals; D005260:Female; D019272:Leukocyte Elastase; D007964:Leukocytosis / Q000378:metabolism / Q000473:pathology*; D008252:Macaca fascicularis; D015735:Mifepristone / Q000008:administration & dosage*; D009504:Neutrophils / Q000378:metabolism / Q000473:pathology*; D010196:Pancreatic Elastase / Q000378:metabolism; D010920:Placenta / Q000378:metabolism* / Q000473:pathology; D011247:Pregnancy; D011266:Pregnancy-Associated Plasma Protein-A / Q000037:antagonists & inhibitors; D011480:Protease Inhibitors / Q000378:metabolism*
chemical_list: D011480:Protease Inhibitors; D015735:Mifepristone; D010196:Pancreatic Elastase; D019272:Leukocyte Elastase; D011266:Pregnancy-Associated Plasma Protein-A